Join Me for a Symposium Exploring How HCV Drugs in Development May Affect Practice Today

[Guest guest]

clinical care options

Having trouble reading this email? Click here to view in your browser.

CME/CE-Certified Symposium

October 20, 2011

The Beckoning Future: How Hepatitis C Drugs in Development May Affect Practice

Today and Tomorrow

Dear colleague,

Please join Nezam H. Afdhal, MD, FRCPI; Lawitz, MD; J. Muir, MD,

MHS, and me

at this live satellite symposium

where we will help providers make informed decisions for today's patients by

examining what the future may hold for hepatitis C management, including:

Prospects and time frame for developing more effective, better tolerated, and/or

more convenient regimens

Need for improved options for patients with non-genotype 1 HCV as well as for

the hardest-to-treat subsets of genotype 1 patients

Challenge of maximizing response rates and avoiding resistance both with today's

regimens and in the future

Clinical dilemmas regarding the risks and benefits of treating patients today vs

awaiting future options

Monday, November 7, 2011

7:00 PM - 7:30 PM Registration and Plated Dinner

7:30 PM - 9:15 PM Symposium

San Francisco Marriott Marquis Hotel

Yerba Buena Ballroom

San Francisco, California

This will be an excellent opportunity to consider the impact of evolving

data on your patients now. I encourage you to register

today.

Regards,

Stefan Zeuzem, MD

Professor of Medicine

Chief, Department of Medicine I

JW Goethe University Hospital

furt, Germany

Presented for attendees of the 62nd AASLD Annual Meeting. This is not

an official function/event of the American Association for the Study of Liver

Diseases.

Click here for more information.

Space is limited! Register for this satellite symposium online at:

http://clinicaloptions.com/Hepatitis/Live%20Events/Satellite%20Symposium/HCV%20F\

uture.aspx

Physicians: Jointly sponsored by Annenberg Center for Health Sciences at

Eisenhower and Clinical Care Options, LLC.

Nurses: Nursing contact hours provided through the coprovidership of

Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options,

LLC.

Annenberg Center for Health Sciences at Eisenhower is accredited as a

provider of continuing nursing education by the American Nurses Credentialing

Center's Commission on Accreditation.

This program is supported by educational grants from Boehringer

Ingelheim, Bristol-Myers Squibb, Janssen Therapeutics, and Pharmasset.

Topics

Fibrosis and Cirrhosis

HIV Coinfection

HBV

NASH, ALD, etc

HCV

Other Hepatitis Viruses

Hepatocellular Carcinoma

Transplantation

Resources

Live Events

Expert Viewpoints

Bookstore

Slideset Downloads

Interactive Tools

Webcasts

Podcasts

Guidelines

Conference Coverage

CME Programs

Slidesets

Cases

Live Events

Bookstore

Resources

Site Map

RSS

Contact Us

Help

Site Requirements

Terms of Use

Privacy Policy

Hepatitis Site Tour

To ensure you receive Clinical Care Options educational materials by email,

please add info@... to your contacts or address book.

Not a member yet? Click here

[Guest guest]

clinical care options

Having trouble reading this email? Click here to view in your browser.

CME/CE-Certified Symposium

October 20, 2011

The Beckoning Future: How Hepatitis C Drugs in Development May Affect Practice

Today and Tomorrow

Dear colleague,

Please join Nezam H. Afdhal, MD, FRCPI; Lawitz, MD; J. Muir, MD,

MHS, and me

at this live satellite symposium

where we will help providers make informed decisions for today's patients by

examining what the future may hold for hepatitis C management, including:

Prospects and time frame for developing more effective, better tolerated, and/or

more convenient regimens

Need for improved options for patients with non-genotype 1 HCV as well as for

the hardest-to-treat subsets of genotype 1 patients

Challenge of maximizing response rates and avoiding resistance both with today's

regimens and in the future

Clinical dilemmas regarding the risks and benefits of treating patients today vs

awaiting future options

Monday, November 7, 2011

7:00 PM - 7:30 PM Registration and Plated Dinner

7:30 PM - 9:15 PM Symposium

San Francisco Marriott Marquis Hotel

Yerba Buena Ballroom

San Francisco, California

This will be an excellent opportunity to consider the impact of evolving

data on your patients now. I encourage you to register

today.

Regards,

Stefan Zeuzem, MD

Professor of Medicine

Chief, Department of Medicine I

JW Goethe University Hospital

furt, Germany

Presented for attendees of the 62nd AASLD Annual Meeting. This is not

an official function/event of the American Association for the Study of Liver

Diseases.

Click here for more information.

Space is limited! Register for this satellite symposium online at:

http://clinicaloptions.com/Hepatitis/Live%20Events/Satellite%20Symposium/HCV%20F\

uture.aspx

Physicians: Jointly sponsored by Annenberg Center for Health Sciences at

Eisenhower and Clinical Care Options, LLC.

Nurses: Nursing contact hours provided through the coprovidership of

Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options,

LLC.

Annenberg Center for Health Sciences at Eisenhower is accredited as a

provider of continuing nursing education by the American Nurses Credentialing

Center's Commission on Accreditation.

This program is supported by educational grants from Boehringer

Ingelheim, Bristol-Myers Squibb, Janssen Therapeutics, and Pharmasset.

Topics

Fibrosis and Cirrhosis

HIV Coinfection

HBV

NASH, ALD, etc

HCV

Other Hepatitis Viruses

Hepatocellular Carcinoma

Transplantation

Resources

Live Events

Expert Viewpoints

Bookstore

Slideset Downloads

Interactive Tools

Webcasts

Podcasts

Guidelines

Conference Coverage

CME Programs

Slidesets

Cases

Live Events

Bookstore

Resources

Site Map

RSS

Contact Us

Help

Site Requirements

Terms of Use

Privacy Policy

Hepatitis Site Tour

To ensure you receive Clinical Care Options educational materials by email,

please add info@... to your contacts or address book.

Not a member yet? Click here